Current trends in drug delivery and excipients in the pharmaceutical industry
An outlook on the importance of excipients by pharmaexcipients which will also be part of the upcomingExciPerienceEvent – March 9 & 10, 2022
Excipients play a crucial role to achieve a drug product and drug delivery profile. With the changes in production options and improvements such as continuous manufacturing and 3D printing as well as enabling new therapies like oral delivery of large molecules and precision medicine the role of excipients from “non-active” ingredient in a formulation has changed to increased functionality and designed for purpose.
A better understanding of the excipients, impact of variabilities on production process, yield and final drug product is fundamental and needs to be addressed. In-Silico, predictive development and artificial intelligence can support the “right first time approach” which can lead to faster and more successful drug product development and lead the industry in the needed direction.
Quality by Design approaches are nowadays standard in the industry but still very focused on the critical process parameters and less on the impact of excipient variations based on the source inherent variabilities due to the nature of the excipient or other factors.
ExciPerienceMarch 9 & 10, 2022 will cover several of these important topics, experts share their valuable insights and discussions will be fostered throughout the event. In a panel session the use ofTitanium Dioxide (TiO2) in pharmaceutical productsand the impact of the ban ofTitanium Dioxide (TiO2) as a food additive will be discussed.
3D printing, Continuous Manufacturing & Drug Delivery
- Keynote: “How3D printing是改变医学”,教授约瑟夫DeSimone
- “Application of lipids in challenging processes: Spray-drying and 3D printing”, Dr Sharareh Salar-Behzadi
- “Formulation trends, including Continuous Manufacturing tableting”,Dr Maj-Britt Cepok
- “Pulmonary Delivery of siRNA as Antiviral Treatment of SARS-CoV-2 Infections”, Prof. Olivia Merkel
In-Silico / Predictive Development and artificial Intelligence
- “In-silico polymer screenings for rational amorphous solid dispersion development”, Dr Christian Lübbert
- “固体pharmace设计的数值方法utical formulations: state of the art, and future challenges”,Dr Maxim Puchkov
- “Opportunity and challenge of artificial intelligence (AI) in drug delivery”, Prof. Defang Ouyang
Gender impact and special patient groups
- “Tumor neurons and patient sex affect nanomedicine efficacy”, Prof. Avi Schroeder
- “Formulations for infants and young children: Innovative use of excipients in filmcoating“, Dr Fang Liu
- “Sex matters: Excipients actively modulate drug response differently in males and females”, Christine Madla, PhD
Excipient Variability and QbD
- “Biopharmaceutical Implications of Excipient Variability on Drug Solubility and Dissolution”, Dr Nikoletta Fotaki
- “Early Phase Pharmaceutical Product Development using Quality by Design tools”, Prof. Walkiria Schlindwein
Excipient Registration
“The complexities of Excipient Registration in China and potential solutions”,Dave Schoneker
and more to be announced shortly…
